K24 CA082754/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2004	1
2010	2
2011	1
2025	0

Page 1

Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.

Winder T, Zhang W, Yang D, Ning Y, Bohanes P, Gerger A, Wilson PM, Pohl A, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ. Winder T, et al. Clin Cancer Res. 2010 Nov 15;16(22):5591-602. doi: 10.1158/1078-0432.CCR-10-2092. Epub 2010 Oct 8. Clin Cancer Res. 2010. PMID: 20935157 Free PMC article.

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ. Stoehlmacher J, et al. Br J Cancer. 2004 Jul 19;91(2):344-54. doi: 10.1038/sj.bjc.6601975. Br J Cancer. 2004. PMID: 15213713 Free PMC article.

Press OA, Zhang W, Gordon MA, Yang D, Haiman CA, Azuma M, Iqbal S, Lenz HJ. Press OA, et al. Pharmacogenomics J. 2011 Oct;11(5):375-82. doi: 10.1038/tpj.2010.45. Epub 2010 Jun 15. Pharmacogenomics J. 2011. PMID: 20548329 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year